Market Tracker

01/30 11:02pm ET

Novavax Inc (NASDAQ:NVAX)

7.81
Data as of Jan 30
 -0.05 / -0.64%
Today’s Change
3.34
Today|||52-Week Range
8.07
+31.70%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close7.86
Today’s open7.82
Day’s range7.74 - 8.07
Volume4,886,077
Average volume (3 months)4,430,249
Market cap$1.9B
Dividend yield--
Data as of 4:00pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)-0.63%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book8.02

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+0.42+0.75%
HALOHalozyme Therapeutic...-0.31-2.12%
FMIFoundation Medicine ...-0.45-0.94%
RLYPRelypsa Inc-0.64-1.79%
Data as of 4:00pm ET, 01/30/2015

Financials

Next reporting dateMarch 30, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts